• Info
  • Insider Ownership

Insider Trading & Ownership of KENNETH BATE

Location
Cambridge, MA
Summary
The estimated net worth of KENNETH BATE is at least $1,295,433 dollars as of 23 Jan 2026. KENNETH BATE is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.29M. KENNETH BATE is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.6K.
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate
All Insider Reports
All Insider Reports

Notify me when KENNETH BATE files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of KENNETH BATE

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $1,289,808 -$18,808,122 -94% 05 Nov 2025
AVEO AVEO PHARMACEUTICALS, INC. Director $5,625 19 Jan 2023
ATXS Astria Therapeutics, Inc. Director 23 Jan 2026
EPZM Epizyme, Inc. Director 12 Aug 2022
GNCA GENOCEA BIOSCIENCES, INC. Director 01 Jul 2021

Insider Transactions Reported by KENNETH BATE:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.